Montelukast for Early Life Wheezing
Public ClinicalTrials.gov record NCT00115297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects of Montelukast on Early Life Wheezing
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will determine the effects of montelukast on the duration of wheezing in children 12 months to 3 years of age who visit a physician for care of a wheezing illness. Only patients from the Ankara area of Hacettepe University Medical Center in Turkey will be included in this study.
Study identification
- NCT ID
- NCT00115297
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Months to 3 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2004
- Primary completion
- Sep 30, 2016
- Completion
- Sep 30, 2016
- Last update posted
- Mar 13, 2017
2004 – 2016
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Massachusetts/UMass Memorial | Worcester | Massachusetts | 01650 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Lung Diseases trials
Other public records listing Lung Diseases. Sorted by last update posted; newest first. Not a recommendation.
- NCT06925373: Housing, Environment, And Living Conditions for Transformed Health Recruiting
- NCT05922761: BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) Recruiting
- NCT07360522: Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting Active, not recruiting
- NCT06004440: Real World Registry for Use of the Ion Endoluminal System Active, not recruiting
- NCT07333183: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD Recruiting
- NCT06494033: Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00115297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00115297 live on ClinicalTrials.gov.